e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Tuberculosis: from bench to bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection
M. Eisenhut, D. Thieme, D. Schmid, S. Luederwald, S. Hans (Luton, United Kingdom; Kreischa, Munich, Germany)
Source:
Annual Congress 2011 - Tuberculosis: from bench to bedside
Session:
Tuberculosis: from bench to bedside
Session type:
Poster Discussion
Number:
1825
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Eisenhut, D. Thieme, D. Schmid, S. Luederwald, S. Hans (Luton, United Kingdom; Kreischa, Munich, Germany). Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection. Eur Respir J 2011; 38: Suppl. 55, 1825
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Non-tuberculous mycobacteria effect in the diagnosis of latent tuberculosis infection in children
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010
Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Source: Eur Respir J 2010; 35: 338-342
Year: 2010
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
The rate of tuberculosis infection in closed contacts of smear positive pulmonary tuberculosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 474s
Year: 2002
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003
The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Latent tuberculosis infection in children in contact with pulmonary tuberculosis patients
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
On tuberculosis and COVID-19 co-infection
Source: Eur Respir J, 56 (2) 2002328; 10.1183/13993003.02328-2020
Year: 2020
Impact of T-SPOT.
TB
test to exclude active
Mycobacterium tuberculosis
complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006
Diagnosis and treatment of latent tuberculosis infection
Source: Eur Respir Monogr 2018; 82: 381-398
Year: 2018
Mycobacterium tuberculosis
bacteremia in reactivation tuberculosis patients without human immunodeficiency virus infection
Source: Eur Respir J 2005; 26: Suppl. 49, 690s
Year: 2005
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1594-1595
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1592-1594
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2015; 46: 1397-1406
Year: 2015
Mycobacterial non-tuberculosis infection in patients operated on for pulmonary tuberculosis
Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease
Year: 2020
Pulmonary tuberculosis relapse or atypical mycobacterium infection?
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
The latent tuberculosis infection among household contacts of newly diagnosed patients with sputum-positive pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 142s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept